ArticleNew microbes and new infections2016
Butyricimonas phoceensis sp. nov., a new anaerobic species isolated from the human gut microbiota of a French morbidly obese patient.
Article in New microbes and new infections, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- From Gut Commensal to Opportunistic Pathogen: A Narrative Review ofAntibiotics (Basel, Switzerland) · 2026Review
- The return of a forgotten ally: tabletop scanning electron microscopy in the realm of bacteriology.Frontiers in cellular and infection microbiology · 2025Review
- Unraveling the mystery: a Mendelian randomized exploration of gut microbiota and different types of obesity.Frontiers in cellular and infection microbiology · 2024Article
- Characterization of Bacterial Microbiota Composition in Healthy and Diarrheal Early-Weaned Tibetan Piglets.Frontiers in veterinary science · 2022Article
- Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France.New microbes and new infections · 2018Article
- From Culturomics to Clinical Microbiology and Forward.Emerging infectious diseases · 2018Article
- Article
Corrections and comments
- Expression of concern · 2024-03-30Concerns/Issues about Human Subject Welfare · Investigation by Journal/Publisher · · Authors' names derived from their Scopus profiles.
- Expression of concern
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Butyricimonas phoceensis strain AT9 (= CSUR 1981 = DSM 100664) was isolated from a stool sample from a morbidly obese French patient living in Marseille using the culturomics approach. The genome of this Gram-negative-staining, anaerobic and non-spore forming rod bacillus is 4 736 949 bp long and contains 3947 protein-coding genes. Genomic analysis identified 173 genes as ORFans (4.5%) and 1650 orthologous proteins (42%) not shared with the closest phylogenetic species, Butyricimonas virosa. Its major fatty acid was the branched acid iso-C15:0 (62.3%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.